Involvement of Purinergic P2 Receptors in Experimental Retinal Neovascularization

REFERENCES

• Lazarowski E, Boucher R, Harden T. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol. 2003; 64: 785–795
   PubMed Web of Science ®Google Scholar
• P2 Receptors. Sigma-Aldrich.com/ehandbook. Rev 2002; 8: 64–67
   Google Scholar
• P2 Receptors: P2Y G-Protein Family. Sigma-Aldrich.com/ehandbook. Rev 2002; 8: 134–137
   Google Scholar
• Lambrecht G, Braun K, Damer S, Ganso M, Hildebrandt C, Ullman H, Kassack M, Nickel P. Structure-activity relationships of suramin, a pyridoxal-5′-phosphate derivative as P2 receptor antagonists. Curr Pharmaceut Des 2002; 8: 2371–2399
   Google Scholar
• Neary J T, Rathbone M P, Cattabeni F, Abbracchio M P, Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 1996; 19: 13–18
   Google Scholar
• Sugioka M, Fukuda Y, Yamashita M. Ca2 + responses to Atp via purinoceptors in the early embryonic chick retina. J Physiol 1996; 493: 855–863
   Google Scholar
• Ianiev I, Uckermann O, Pannicke T, Wurm A, Tenckhoff S, Pietsch U, Reichenbach A, Wiedemann P, Bringmann A, Uhlmann S. Glial cell reactivity in a porcine model of retinal detachment. Invest Ophthalmol Vis Sci 2006; 47: 2161–2171
   Google Scholar
• Francke M, Weick M, Pannicke T, Uckermann O, Grosche J, Goczalik I, Milenkovic I, Uhlmann S, Faude F, Wiedemann P, Reichenbach A, Bringmann A. Up-regulation of extracellular Atp-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2002; 43: 870–881
   Google Scholar
• Sugiyama T, Kabayashi M, Kawamura H, Li Q, Puro D. Enhancement of P2X7-induced pore formation and apoptosis: An early effect of diabetes on the retinal microvasculature. Invest Ophthalmol Vis Sci 2004; 45: 1026–1032
   PubMedGoogle Scholar
• Sugiyama T, Oku H, Komori A, Ikeda T. Effect of P2X7 receptor activation on the retinal blood velocity of diabetic rabbits. Arch Ophthalmol 2006; 124: 1143–1149
   Google Scholar
• Sugiyama T, Kawamura H, Yamanishi S, Kobayashi M, Katsumura K, Puro D. Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvessels. Am J Physiol Cell Physiol 2005; 288: C568–C576
   Google Scholar
• Francke H, Klimke K, Brinckmann U, Grosche J, Francke M, Sperlagh B, Reichenbach A, Liebert U G, Illes P. P2X(7) receptor-mRna and protein in the mouse retina; changes during retinal degeneration in Balbcrds mice. Neurochem Int 2005; 47: 235–242
   Google Scholar
• Bucolo C, Marrazzo A, Ronsisvalle S, Ronsisvalle G, Cuzzocrea S, Mazzon E, Caputi A, Drago F. A novel adamantane derivative attenuates retinal ischemic-reperfusion damage in the rat retina through σ1 receptors. Eur J Pharmacol 2006; 536: 200–203
   PubMed Web of Science ®Google Scholar
• Osborne N, Schwarz M, Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest Ophthalmol. Vis Sci 1996; 37: 274–280
   Google Scholar
• Siesjo B K. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77: 169–184
   PubMed Web of Science ®Google Scholar
• Morigiwa K, Quan M, Murakami M, Yamashita M, Fukuda Y. P2 purinoceptor expression and functional changes of hypoxia-activated cultured rat retinal microglia. Neurosci Lett 2002; 282: 153–156
   Google Scholar
• Fruttiger M. Development of the mouse retinal vasculature: Angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 2002; 43: 522–527
   PubMed Web of Science ®Google Scholar
• Yancopoulos G D, Davis S, Gale N W, Rudge J S, Wiegand S J, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000; 407: 249–257
   Google Scholar
• Carmeliet P, Jain R K. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–257
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653–660
   PubMed Web of Science ®Google Scholar
• Smith L, Wesolowski E, McLellan A, Kostyk S, D'Amato R, Sullivan R, D'Amore P. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35: 101–111
   PubMed Web of Science ®Google Scholar
• Eichhorst S, Krueger A, Müerköster S, Fas S, Golks A, Gruetzner U, Schubert L, Opelz C, Bilzer M, Gerbes A, Krammer P. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med 2004; 10: 602–609
   PubMed Web of Science ®Google Scholar
• Honore P, Mikusa J, Bianchi B, McDonald H, Cartmell J, Faltynek C, Jarvis M. Tnp-Atp, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: Comparison with reference analgesics. Pain 2002; 96: 99–105
   PubMed Web of Science ®Google Scholar
• Greenwood D, Yao W, Housley G. Expression of the P2X2 receptor subunit of the Atp-gated ion channel in the retina. Neuroreport 1997; 8: 1083–1088
   Google Scholar
• Kaneda M, Ishii K, Morishima Y, Akagi T, Yamazaki Y, Nakanishi S, Hashikawa T. Off-cholinergic-pathway-selective localization of P2X2 purinoceptors in the mouse retina. J Comp Neurol 2004; 476: 103–111
   Google Scholar
• Puthussery T, Fletcher E. P2X2 receptors on ganglion and amacrine cells in cone pathways of the rat retina. J Comp Neurol 2006; 496: 595–609
   Web of Science ®Google Scholar
• Fries J, Wheeler-Schilling T, Guenther E, Kohler K. Expression of P2Y1, P2Y2, P2Y4 and P2Y6 receptor subtypes in the rat retina. Invest Ophthalmol Vis Sci 2004; 45: 3410–3417
   Google Scholar
• Fries J, Wheeler-Schilling T, Kohler K, Guenther E. Distribution of metabotropic P2Y receptors in the rat retina: A single-cell Rt-Pcr study. Mol Brain Res 2004; 130: 1–6
   Google Scholar
• Cavaliere F, Florenzano F, Amadio S, Fusco F, Viscomi M, D'Ambrosi N, Vacca F, Sancesario G, Bernardi G, Molinari M, Volonte C. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: Prevention by P2 antagonists. Neuroscience. 2003; 120: 85–98
   PubMed Web of Science ®Google Scholar
• Waltenberger J, Mayr U, Frank H, Hombach V. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol 1996; 28: 1523–1529
   PubMed Web of Science ®Google Scholar
• Kathir K, Kumar T, Yu C. Understanding the mechanism of the antimitogenic activity of suramin. Biochemistry. 2006; 45: 899–906
   PubMed Web of Science ®Google Scholar